SCHEMBL188859

SCHEMBL188859

CC(COc1ccc(N)cc1)CN(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.53
TSHR P16473 1/20 0.47
HIF1A Q16665 2/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 4/20 0.41
HPGD P15428 1/20 0.41
GPR88 Q9GZN0 1/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
RAB9A P51151 2/20 0.38
APP P05067 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14407437 0.85 TDP1 (0.59) TDP1TSHRALDH1A1MAPTGAA
SCHEMBL14076211 0.81 LMNA (0.55) TDP1TSHRHIF1AALDH1A1GPR88
SCHEMBL188449 0.81 HIF1A (0.65) TDP1HIF1AHTTALDH1A1HPGD
Hydrochloric Acid SCHEMBL5257349 0.79 HIF1A (0.68) HIF1AHTTALDH1A1HPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL5396629 0.79 HIF1A (0.68) HIF1AHTTALDH1A1HPGDSMN1; SMN2
SCHEMBL188875 0.78 TDP1 (0.52) TDP1TSHRALDH1A1MAPTGAA
SCHEMBL6181040 0.78 TDP1 (0.52) TDP1TSHRALDH1A1MAPTGAA
SCHEMBL109648 0.77 TDP1 (0.64) TDP1TSHRALDH1A1HPGDMAPT
Hydrochloric Acid SCHEMBL738082 0.75 TDP1 (0.62) TDP1TSHRALDH1A1HPGDMAPT
SCHEMBL14287613 0.74 ABCB1 (0.63) TSHRHTTALDH1A1GPR88MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288396-B2 Pyrimidopyrimidoindazole derivative MSDKK (JP) 2012-10-16 US disclosed
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-05-31 US disclosed
EP-2401281-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-01-04 EP disclosed
WO-2010098367-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-09-02 WO disclosed
WO-2010098367-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE WEE1, WEE2, DCK TDP1 2230/4885TSHR 1156/4885HIF1A 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.